A recent study reveals that an ERK1/2 inhibitor blocks the upregulation of BDNF induced by MK-801, which mimics schizophrenia-like symptoms in healthy individuals [79], suggesting that ERK1/2 plays a critical role in schizophrenia. The gene discussed is MAPK3; the disease is schizophrenia.